Singapore, March 27 -- On March 26, Microsoft (MS) CEO Satya Nadella arrived in Korea for the Microsoft AI Tour in Seoul, a forum that brought together Korean firms involved in Microsoft's AI ecosystem to present their model use cases to participants.
Among healthcare companies,Seegene, a Korean diagnostics solutions company, showcased its use of Microsoft's artificial intelligence (AI) technologies in expediting diagnostic reagent development processes during the forum.
During a panel discussion focused on the healthcare industry, Seegene introduced its plans to leverage Microsoft's Azure OpenAI Service in its diagnostic reagent development processes.Azure OpenAI provides API access to OpenAI's language models, such as GPT-4, through M...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.